4 results match your criteria: "University Hospital of Brest - La Cavale Blanche[Affiliation]"
Obesity (Silver Spring)
September 2021
Univ Lille, Inserm, Lille Pasteur Institute, European Genomic Institute for Diabetes, U1190, F-59000, Lille, France.
Ann Intensive Care
December 2018
Department of Intensive Care Medicine, University Hospital of Brest - La Cavale Blanche, Boulevard Tanguy Prigent, 29609, Brest Cedex, France.
Objective: To assess how stressful conditions in endotracheal intubation could induct emotional excitation in a population of acute care physicians.
Materials And Methods: Two situations were randomly tested: one in standard and easy intubation conditions the other under difficult conditions presumed to induce stress (monitoring alarms, manikin lying on the floor, difficult intubation). Emotional excitation was assessed using several physiological (cardiac patterns, electrodermal activity and eye-tracking) and psycho-cognitive patterns.
Eur J Gastroenterol Hepatol
February 2016
aDepartment of Hepato-Gastroenterology bDepartment of Internal Medicine, University Hospital of Brest La Cavale Blanche, Brest cHepatology Department, Pontchaillou University Hospital, Rennes dDepartment of Hepatology and Gastroenterology, Laennec Hospital-GHPSO, Creil, France.
Background And Aims: In many countries, current treatment for patients with chronic hepatitis C involves a combination of peginterferon and ribavirin, associated with a protease inhibitor for hepatitis C virus genotype 1. More recent and efficient less toxic antiviral treatments are now available for some patients. Thus, the decision to treat or to wait is challenging.
View Article and Find Full Text PDFDiabetes Metab Syndr Obes
October 2015
Department of Endocrinology, Diabetology and Metabolic Diseases, Medical University Hospital of Brest La Cavale Blanche, Brest, France.
Insulin degludec (IDeg) is a novel antiglycemic agent belonging to the therapeutic class of ultra-long duration basal insulin analogs. Its half-life and duration of action are 25 hours and 42 hours, respectively. This pharmacodynamic profile leads to a strict dosing schedule, ie, IDeg is injected at the same time each day to ensure optimal biological action and consistent glycemic control.
View Article and Find Full Text PDF